- Home
- LIPO
as 02-21-2025 4:00pm EST
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
Upcoming Earnings Alert:
Get ready for potential market movements as Lipella Pharmaceuticals Inc. LIPO prepares to release earnings report on 28 Feb 2025.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | PITTSBURGH |
| Market Cap: | 3.1M | IPO Year: | 2022 |
| Target Price: | $16.00 | AVG Volume (30 days): | 6.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.21 - $12.00 | Next Earning Date: | 02-28-2025 |
| Revenue: | $483,533 | Revenue Growth: | 0.78% |
| Revenue Growth (this year): | -17.65% | Revenue Growth (next year): | N/A |
Latest Lipella Pharmaceuticals Inc. News
LIPO Breaking Stock News: Dive into LIPO Ticker-Specific Updates for Smart Investing
MT Newswires
12 days ago
Top Midday Gainers
MT Newswires
12 days ago
Lipella Pharmaceuticals Shares Rise After Positive Phase 2a Trial Results for Oral Lichen Planus Treatment
Benzinga
12 days ago
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
MT Newswires
12 days ago
Top Premarket Gainers
GlobeNewswire
12 days ago
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
MT Newswires
17 days ago
Top Midday Gainers
MT Newswires
17 days ago
Top Premarket Gainers
GlobeNewswire
17 days ago
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Compare LIPO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LIPO Lipella Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.